|
ANKRD57 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.245700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.830100E-04 |
| Normal-vs-Stage2 |
9.73930000000012E-05 |
| Normal-vs-Stage3 |
2.368200E-04 |
| Normal-vs-Stage4 |
3.965900E-04 |
| Stage1-vs-Stage2 |
7.112100E-02 |
| Stage1-vs-Stage3 |
3.022600E-01 |
| Stage1-vs-Stage4 |
4.510800E-01 |
| Stage2-vs-Stage3 |
4.170000E-01 |
| Stage2-vs-Stage4 |
4.339200E-01 |
| Stage3-vs-Stage4 |
9.296600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.449500E-04 |
| Normal-vs-AfricanAmerican |
1.640050E-02 |
| Normal-vs-Asian |
1.198380E-03 |
| Caucasian-vs-AfricanAmerican |
1.430220E-01 |
| Caucasian-vs-Asian |
6.575800E-01 |
| AfricanAmerican-vs-Asian |
3.692200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.195810E-04 |
| Normal-vs-Female |
5.735600E-03 |
| Male-vs-Female |
2.456200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.223830E-02 |
| Normal-vs-Extreme_Weight |
1.009670E-04 |
| Normal-vs-Obese |
2.557600E-04 |
| Normal-vs-Extreme_Obese |
1.555050E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.927400E-01 |
| Normal_Weight-vs-Obese |
4.745400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.978400E-01 |
| Extreme_Weight-vs-Obese |
2.340200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.053000E-01 |
| Obese-vs-Extreme_Obese |
9.091600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.635420E-03 |
| Normal-vs-Age(41-60Yrs) |
4.978400E-04 |
| Normal-vs-Age(61-80Yrs) |
2.592700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.207140E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.840000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.728210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.284300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.911200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.798560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.108000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.220580E-04 |
| Normal-VS-Type2 PRCC |
5.943200E-03 |
| Normal-VS-KIRP CIMP |
1.522410E-02 |
| Normal-VS-Unclassified PRCC |
1.161990E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.869200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.627300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
7.896800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.270400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.694780E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.063350E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.64710000000779E-05 |
| Normal-vs-N1 |
3.392800E-04 |
| Normal-vs-N2 |
1.729990E-01 |
| N0-vs-N1 |
1.425210E-01 |
| N0-vs-N2 |
3.908400E-01 |
| N1-vs-N2 |
8.943000E-01 |
|
|
